Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor- B and activator protein-1 related mechanisms
Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor- B and activator protein-1 related mechanisms
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now